BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7788624)

  • 21. Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking.
    Balldin J; Berggren U; Engel J; Eriksson M
    Alcohol Clin Exp Res; 1994 Aug; 18(4):822-5. PubMed ID: 7978090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review.
    Newman ME; Shapira B; Lerer B
    Int J Neuropsychopharmacol; 1998 Jul; 1(1):49-69. PubMed ID: 11281946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function.
    O'Keane V; Moloney E; O'Neill H; O'Connor A; Smith C; Dinan TG
    Br J Psychiatry; 1992 May; 160():643-6. PubMed ID: 1591573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonergic responsiveness in human cocaine users.
    Ghitza UE; Rothman RB; Gorelick DA; Henningfield JE; Baumann MH
    Drug Alcohol Depend; 2007 Jan; 86(2-3):207-13. PubMed ID: 16930852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neuroendocrine response to d-fenfluramine in women with premenstrual depression.
    Bancroft J; Cook A
    J Affect Disord; 1995 Dec; 36(1-2):57-64. PubMed ID: 8988266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin function following remission from bulimia nervosa.
    Wolfe BE; Metzger ED; Levine JM; Finkelstein DM; Cooper TB; Jimerson DC
    Neuropsychopharmacology; 2000 Mar; 22(3):257-63. PubMed ID: 10693153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenfluramine and idiopathic pain: a serotonergic study in non-psychiatric patients with functional gastrointestinal disorder.
    Tanum L; Bråtveit-Johansen K; Malt UF
    Scand J Gastroenterol; 1998 Jul; 33(7):684-90. PubMed ID: 9712230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactin and cortisol responses to fenfluramine in Parkinson's disease.
    Kostić VS; Lecić D; Doder M; Marinković J; Filipović S
    Biol Psychiatry; 1996 Oct; 40(8):769-75. PubMed ID: 8894070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine responses to challenge with dl-fenfluramine and aggression in disruptive behavior disorders of children and adolescents.
    Stoff DM; Pasatiempo AP; Yeung J; Cooper TB; Bridger WH; Rabinovich H
    Psychiatry Res; 1992 Sep; 43(3):263-76. PubMed ID: 1438624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonergic responsivity in eating disorders.
    McBride PA; Anderson GM; Khait VD; Sunday SR; Halmi KA
    Psychopharmacol Bull; 1991; 27(3):365-72. PubMed ID: 1775611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P; Smythe G; Parker G; Wilhelm K; Hickie I; Brodaty H; Boyce P
    Br J Psychiatry; 1990 Oct; 157():551-7. PubMed ID: 2131137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin activity in anorexia nervosa after long-term weight restoration: response to D-fenfluramine challenge.
    O'Dwyer AM; Lucey JV; Russell GF
    Psychol Med; 1996 Mar; 26(2):353-9. PubMed ID: 8685291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects.
    Gorard DA; Taylor TM; Medbak SH; Perry LA; Libby GW; Farthing MJ
    Int Clin Psychopharmacol; 1993; 8(2):123-8. PubMed ID: 8393895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal responses to dl-fenfluramine challenge are not blunted in seasonal affective disorder.
    Yatham LN; Michalon M
    Psychoneuroendocrinology; 1995; 20(4):433-8. PubMed ID: 8532826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet monoamine oxidase B (MAO-B) activity and its relationship to DL-fenfluramine-induced prolactin response in healthy men.
    Eriksson M; Berggren U; Fahlke C; Engel J; Balldin J
    J Neural Transm (Vienna); 2006 Jan; 113(1):33-41. PubMed ID: 15959855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD.
    Hollander E; Cohen LJ; DeCaria C; Saoud JB; Stein DJ; Cooper TB; Islam NN; Liebowitz MR; Klein DF
    Biol Psychiatry; 1993 Sep; 34(6):407-13. PubMed ID: 8218609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine correlates of temperamental traits in humans.
    Gerra G; Zaimovic A; Timpano M; Zambelli U; Delsignore R; Brambilla F
    Psychoneuroendocrinology; 2000 Jul; 25(5):479-96. PubMed ID: 10818282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin function in detoxified heroin abusers: prolactin and cortisol responses to fenfluramine challenge.
    Gerra G; Fertonani G; Tagliavini P; Zaimovic A; Delsignore R; Maestri D; Avanzini P; Caccavari R; Brambilla F
    Psychiatry Res; 1995 Sep; 58(2):153-60. PubMed ID: 8570767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine responses after d-fenfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality.
    Hennig J; Toll C; Schonlau P; Rohrmann S; Netter P
    Neuropsychobiology; 2000; 41(1):38-47. PubMed ID: 10629434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
    Abel KM; O'Keane V; Murray RM
    Br J Psychiatry; 1996 Jan; 168(1):57-60. PubMed ID: 8770429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.